STING1 and neoplasm: Furthermore, radiotherapy can also promote anti-tumor immunity by activating immune pathways in tumor microenvironment (for example, cGAS-STING induces type I interferon response), thus providing a theoretical basis for the combined application of sensitizer and immunotherapy [5,6].